Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING · MEDICINAL AND BOTANICAL MANUFACTURING · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Fighting stance · agency mix
3 agenciesRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
$90 for 90 days · $1 a day · one recompete pays for a decade of it.
Verify any number on this page. The analysis is the part you can't self-serve.
See where they're vulnerable — $90 Pilot →No recompetes on this account — see where they're vulnerable instead. Displacement scoring + whitespace signals in the 90-day pilot.
90 days · $90 · no annual contract · cancel anytime
Recompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
$1 a day. One recompete pays for a decade.
This page stays free — verify any figure yourself. Pilot is the live layer: displacement scoring, alerts, and a 90-day capture workflow you can't self-serve.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
No recompetes on this account — see where they're vulnerable instead. Displacement scoring + whitespace signals in the 90-day pilot.
90 days · $90 · no annual contract · cancel anytime
Already subscribed? Jump straight into Global Blood Therapeutics in the SCOUT app — same UEI context, with CTA attribution.
Others competing in Global Blood Therapeutics's NAICS lane — open a profile to compare footprint and recompetes.
Browse live recompete landscapes by vehicle, agency, and set-aside.
Submit your UEI and we’ll generate your federal profile. We’ll email you when it’s live.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP → · Start a $90 Pilot →
Frequently asked questions
What federal contracts does Global Blood Therapeutics hold?
Global Blood Therapeutics (UEI MHBQULRMEEJ5) shows $3.2B across 1961 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Global Blood Therapeutics work with?
Global Blood Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%), Department of Defense (DOD) (0%), Department of Veterans Affairs (VA) (0%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →